SCHEMBL6965576

SCHEMBL6965576

CC(C)CC(SCc1ccccc1)c1c(O)cc(C2=COC=C(C3=CC=CCC3)O2)oc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954004 0.76 SMN1; SMN2 (0.41)
SCHEMBL6966327 0.73
SCHEMBL6954761 0.73
SCHEMBL6965574 0.72 ALDH1A1 (0.42)
SCHEMBL6953958 0.68 ABCB1 (0.38)
SCHEMBL7409285 0.68 ABCB1 (0.39)
SCHEMBL6954417 0.66 MEN1 (0.30)
SCHEMBL6954754 0.63 SMN1; SMN2 (0.40)
SCHEMBL6963486 0.62 ABCB1 (0.38)
SCHEMBL6956690 0.62 SMN1; SMN2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed